By inducing immunogenic tumor cell lysis and releasing damage-associated molecular patterns (DAMPs), type I interferons, and chemokines (CXCL9/10), they enhance the recruitment of CD8+ T cells into the tumor milieu (252). The gene discussed is CD8A; the disease is neoplasm.